Search

Results 1-10 of 170
Publication DateTitleAuthor(s)
31-Jul-2015Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, K; Hasegawa, K; Yoshino, K; Murakami, R; Hisamatsu, T, et al
10-Jan-2017CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolitesSood, D; Johnson, N; Jain, P; Siskos, AP; Bennett, M, et al
28-Apr-2016Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activityLubecka, K; Kurzava, L; Flower, K; Buvala, H; Zhang, H, et al
24-Mar-2017Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is down-regulated in metaplastic breast cancerYague, E; Asaduzzaman, M; Constantinou, S; Haoxiang, M; Gallon, J, et al
1-Jun-2015Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancerZhang, H; Angelopoulos, N; Xu, Y; Grothey, A; Nunes, J, et al
25-Oct-2014Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathwayAlshaker, H; Krell, J; Frampton, AE; Waxman, J; Blyuss, O, et al
12-Nov-2013SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1Zhang, H; Xu, Y; Filipovic, A; Lit, LC; Koo, C-Y, et al
17-Sep-2013'Being there' for women with metastatic breast cancer: a pan-European patient surveyHarding, V; Afshar, M; Krell, J; Ramaswami, R; Twelves, CJ, et al
11-Jun-2014Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cellsLombardo, Y; Faronato, M; Filipovic, A; Vircillo, V; Magnani, L, et al
30-Apr-2013Circulating microRNAs as potential new biomarkers for prostate cancerSita-Lumsden, A; Dart, DA; Waxman, J; Bevan, CL